Sequencing Abiraterone and Enzalutamide in mCRPC

NCT02125357 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

202

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Castration-Resistant Prostate Cancer

Interventions

DRUG: Abiraterone acetate
DRUG: Enzalutamide

Sponsor

British Columbia Cancer Agency